market-driven impact
Your Scientific and Regulatory Strategic Partner
Galileo Research is specialized in non-clinical Discovery and Development services for the Life Sciences sector. Our expertise empowers companies in the pharmaceutical, medical device, novel foods, and dietary supplements industries to accelerate innovation and bring safe, effective products to the market.
We provide expert Scientific and Regulatory Advice to help companies navigate the complexities of non-clinical testing, biocompatibility, toxicity studies, and more. With decades of multidisciplinary experience and industry-specific focus, we are a strategic partner in transforming your discoveries into tangible, market-ready products.
A Collaborative Approach to Research & Development
Galileo Research works closely with clients and partners, fostering transparent communication and a shared commitment to success. Our collaborative research approach and strategic planning expertise ensure stakeholders stay informed with real-time updates, allowing for agile decision-making and timely adjustments throughout the R&D process.
Commitment to Quality and Compliance
Established in 2011 as a spin-off from Abiogen Pharma’s R&D division, Galileo Research operates under the highest international guidelines and standards. Our product development studies strictly adhere to ICH, OECD, ISO, and EFSA guidelines and are conducted in compliance with Good Laboratory Practice (GLP), a certification held from the Italian Health Authorities since 1992. Galileo Research is authorized to perform both regulatory and exploratory studies in vivo.